RxDoctor Payments Data

Owen Glotzer, MD

Vascular Surgery · Hartford, CTNPI 1831583749

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.2%), grants and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 72.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $4,664 and has fallen 60.2% since, to $1,859 in 2025.

$12,336in general payments, 2019–2025

Across 102 payments — averaging $120.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • W. L. Gore & Associates, Inc.$1K
  • Cook Incorporated$797
  • Cook Medical LLC$548
  • Inari Medical, Inc.$412
  • Terumo Medical Corporation$185
  • plus $398 from 6 others

What the payments were for

  • Grants$4,00032%
  • Travel & lodging$2,32819%
  • Food & beverage$4,71038%
  • Education$1,29811%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,336 in reported general payments places this provider in the 60th percentile of 82 vascular surgery providers in Connecticut.

See all vascular surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$136,142
Medicare patients
273
Services billed
586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban31$25,872
EliquisApixaban14$11,527
ClopidogrelClopidogrel Bisulfate89$730
Atorvastatin Calcium22$89
Cilostazol21$86

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →